Tuesday, 29 April 2025
  
Login

Australia's most trusted
source of pharma news

Tuesday, 29 April 2025
Ascott/IQVIA
Ascott/IQVIA
Albo law to shake-up pharma jobs

If the Albanese Government is returned to power this weekend a decision to ban non-compete clauses in employment contracts could have a far-reaching impact on the pharma jobs market - including pay rises.

One submission wonder hits PBS
AbbVie's major blood cancer drug and pegged blockbuster has made a speedy appearance on the PBS after just one PBAC submission
TODAY
Big plans for ex-Novartis drug
Multinational pharma currently in the set-up and pre-launch phase in Australia reveals what's in the works
TODAY
ARCS
ARCS
71% of drugs pass PBAC muster
But the controversial March meeting was a mixed bag with some of the biggest names failing to make the cut
28 April
Yes... but with a price reduction
While all new indications, population expansions and earlier lines were recommended, economic modelling was a problem
28 April
Approval tainted by PBAC 'No'
Good and bad news as cancer drug earns a tick from the TGA but a thumbs down for reimbursement
28 April Approvals Action
Finally, a PBS listing after 1514 days
At last J&J treatment hits the PBS after four rounds with PBAC, ending a 30-year treatment drought for patients
28 April
Latest Jobs
TGA hunting Committee experts
The regulator is hiring, looking for medicine experts to fill positions on seven of its committees to provide independent advice
28 April
$300M windfall for Aussie boss
Freshly-minted billionaire cashes out a significant part of his holdings in the pharma retail and wholesale giant
24 April
How Pfizer CEO delighted the Pope
Ahead of the Pope's funeral this weekend, Pfizer boss Albert Bourla reveals the words that made the Pontiff's eyes light up
24 April
Sanofi flashes blockbuster arsenal
Two of 2025's biggest names have made their first regulatory appearance in Australia, among six newcomers
24 April
PBS could become a 'brutal jungle'
What's at stake if Donald Trump resurrects international price referencing and what Aussie pharma execs should do about it
24 April
Doctors snub pharma on AI
HCPs believe pharma could better leverage AI to support them but are skeptical about using the AI help that industry provides
24 April
No promises on faster PBS listings
Debate between Health Minister Mark Butler and his Shadow Anne Ruston fails to secure timeline for faster medicines access
23 April
Sherlock Holmes takes on cancer
New Pfizer campaign uses famous stories to rewrite the narrative of a cancer diagnosis
23 April
KOLs earning most from pharma
New analysis reveals which HCPs have received the highest payments from pharma and which therapy areas attract most investment
23 April
Biologics to double COPD market
A new treatment paradigm supported by precision medicine will drive significant change in the market
23 April
Industry fails on patient-centricity
Fewer than one in five patients surveyed 'strongly agree' industry is patient-centric, prioritising their needs and preferences
23 April
Top earning CEO crown goes to...
Years of cumulative success has propelled a new CEO to the top of the highest-paid list. Find out who it is
22 April
Who's spending the most on HCPs?
Which company has retained its crown as the pharma with the highest spend on HCPs, according to the latest transparency data
22 April
RCA calls truce on PBAC bickering
Respected industry body expresses disappointment at both Government and industry for sniping that does nothing to help patients
22 April
PiF Job Rate
PiF Job Rate
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.